Cole W Peters

6PUBLICATIONS
37CO-AUTHORS
Haematological tumoursNeural engineeringGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.

Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters

|Jan 07, 2025
Cell-specific delivery of GJB2 restores auditory function in mouse models of DFNB1 deafness and mediates appropriate expression in NHP cochlea.

Maryna V Ivanchenko, Kevin T A Booth, K Domenica Karavitaki

|Nov 28, 2023
PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1F.

Maryna V Ivanchenko, Daniel M Hathaway, Eric M Mulhall

|Oct 23, 2023
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.

Theodore S Nowicki, Cole W Peters, Crystal Quiros

|Oct 19, 2022
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy.

Jack Pengfei Tang, Cole W Peters, Crystal Quiros

|Mar 31, 2018
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.

Dipongkor Saha, Hiroaki Wakimoto, Cole W Peters

Pageof 1

Frequent Collaborators

3 joint publications

Alexandra M Klomhaus

3 joint publications

Theodore S Nowicki

2 joint publications

David P Corey

2 joint publications

Crystal Quiros